Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL681238 | 0.87 | ALDH1A1 (0.41) | ALDH1A1TDP1MEN1CYP1A2THRB | |
| SCHEMBL6844307 | 0.82 | ALDH1A1 (0.56) | ALDH1A1FFAR3MEN1CYP1A2THRB | |
| SCHEMBL27991129 | 0.81 | — | — | |
| SCHEMBL4957127 | 0.81 | — | — | |
| SCHEMBL29116160 | 0.80 | ALDH1A1 (0.38) | ALDH1A1MEN1CYP1A2THRBKMT2A | |
| SCHEMBL29116162 | 0.80 | — | — | |
| SCHEMBL21840420 | 0.79 | TSHR (0.30) | — | |
| SCHEMBL8489844 | 0.77 | DGAT1 (0.43) | ALDH1A1TDP1MEN1CYP1A2THRB | |
| SCHEMBL16297377 | 0.76 | ALDH1A1 (0.32) | ALDH1A1TDP1FFAR3MEN1CYP1A2 | |
| SCHEMBL29280668 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040005708-A1 | Polypeptide derivatives and nucleic acid carriers containing the same | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2004-01-08 | — | — | US | disclosed |
| EP-1285942-A1 | POLYPEPTIDE DERIVATIVES AND NUCLEIC ACID CARRIERS CONTAINING THE SAME | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2003-02-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040005708-A1 | Polypeptide derivatives and nucleic acid carriers containing the same | POLRMT, TAP1, RNASE1 | ALDH1A1 1107/4885TDP1 30/4885FFAR3 3972/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.